Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 24.46
-1.77 %
$ 991 M
Market Cap
56.88
P/E
Price Target
Average
--23.68%
Revenue Forecast
Estimate
6.26%
EBIT
Estimate
17.73%
Net Income
Estimate
157.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Phibro Animal Health Corporation
Wall Street analysts predict an average 1-year price target for PAHC of $18.7 , with forecasts ranging from a low of $17 to a high of $21 .
PAHC Lowest Price Target
Wall Street Target
17 USD
-30.50%
PAHC Average Price Target
Wall Street Target
18.7 USD
-23.68%
PAHC Highest Price Target
Wall Street Target
21 USD
-14.15%
REVENUE FORECAST
Revenue Forecast Chart PAHC
EBIT FORECAST
EBIT Forecast Chart PAHC
NET INCOME FORECAST
Net Income Chart PAHC